BioCentury | Jan 13, 2021
Management Tracks

Spark vet High joins AskBio; plus Rotthier to lead Sanofi API unit and moves at Immunovant, Innocoll

...that, VP of men’s and women’s health and metabolic development at AbbVie Inc. (NYSE:ABBV).Spec pharma Innocoll...
...while remaining president. He succeeds Rich Fante at the Gurnet Point portfolio company. Jeff Cranmer Sanofi Asklepios BioPharmaceutical Inc. Innocoll Immunovant...
BioCentury | Mar 9, 2019
Company News

Management tracks: Lundbeck hires first CBO; ICT opens U.S. office

...of its pipeline. Draeger was CEO of Nurevas International AG (Binningen, Switzerland). Postsurgical pain company Innocoll...
BioCentury | May 17, 2017
Company News

Management tracks

...endocrine diseases play Radius Health Inc. (NASDAQ:RDUS) named Jose Carmona CFO. He was CFO at Innocoll...
BioCentury | Jan 3, 2017
Clinical News

XaraColl regulatory update

...FDA issued a refusal to file letter for an NDA from Innocoll for XaraColl bupivacaine collagen-matrix...
...XaraColl should be characterized as a drug/device combination, a complete application would require additional information. Innocoll...
...membrane technology. Innocoll Holdings plc (NASDAQ:INNL), Athlone, Ireland Product: XaraColl bupivacaine collagen-matrix implants Business: Neurology Julian Zhu XaraColl Innocoll...
BioCentury | Nov 22, 2016
Clinical News

XaraColl regulatory update

...Innocoll Holdings plc (NASDAQ:INNL), Athlone, Ireland Product: XaraColl , Bupivacaine collagen sponge Business: Neurology Jaime De Leon XaraColl Innocoll...
BioCentury | Nov 22, 2016
Clinical News

Cogenzia: Ph III COACT-1 and COACT-2 data

...about 10 days post-treatment vs. placebo plus SOC or SOC alone. Cogenzia was well tolerated. Innocoll...
...clinical cure, amputation rate and ulcer closure rate Status: Phase III data Milestone: NA Jaime De Leon Cogenzia Innocoll...
BioCentury | Nov 14, 2016
Clinical News

XaraColl regulatory update

...membrane technology. Innocoll Holdings plc (NASDAQ:INNL), Athlone, Ireland Product: XaraColl bupivacaine collagen-matrix implants Business: Neurology Nora Weintraub XaraColl Innocoll...
BioCentury | Oct 3, 2016
Finance

ASH and others

...III data December Indivior plc (LSE:INDV) RBP-7000 Acute exacerbation of schizophrenia Ph III data 4Q16 Innocoll...
...NASDAQ:INNL) Cogenzia CollaRx gentamicin topical Moderate or severe diabetic foot infections Ph III data 4Q16 Innocoll...
BioCentury | Jul 11, 2016
Finance

Ground up

...comes together quickly. Announcing publicly can be a no-win situation." The most notable example was Innocoll...
...London, U.K. Juno Therapeutics Inc. (NASDAQ:JUNO), Seattle, Wash. Kite Pharma Inc. (NASDAQ:KITE), Los Angeles, Calif. Innocoll...
...6/17/16 $20.1 $138.2 $164.7 16% BioTime Inc. (NYSE-M:BTX; Tel Aviv:BTX) 6/16/16 $17.5 $244.5 $267.0 8% Innocoll...
BioCentury | Jul 11, 2016
Finance

Rethinking risk

...2H16 Horizon Pharma plc (NASDAQ:HZNP) Actimmune interferon gamma-1b Friedreich's ataxia Top-line Ph III data YE16 Innocoll...
...Holdings plc (NASDAQ:INNL) Cogenzia Diabetic foot infections Top-line Ph III COACT-1 and COACT-2 data 2H16 Innocoll...
Items per page:
1 - 10 of 83
BioCentury | Jan 13, 2021
Management Tracks

Spark vet High joins AskBio; plus Rotthier to lead Sanofi API unit and moves at Immunovant, Innocoll

...that, VP of men’s and women’s health and metabolic development at AbbVie Inc. (NYSE:ABBV).Spec pharma Innocoll...
...while remaining president. He succeeds Rich Fante at the Gurnet Point portfolio company. Jeff Cranmer Sanofi Asklepios BioPharmaceutical Inc. Innocoll Immunovant...
BioCentury | Mar 9, 2019
Company News

Management tracks: Lundbeck hires first CBO; ICT opens U.S. office

...of its pipeline. Draeger was CEO of Nurevas International AG (Binningen, Switzerland). Postsurgical pain company Innocoll...
BioCentury | May 17, 2017
Company News

Management tracks

...endocrine diseases play Radius Health Inc. (NASDAQ:RDUS) named Jose Carmona CFO. He was CFO at Innocoll...
BioCentury | Jan 3, 2017
Clinical News

XaraColl regulatory update

...FDA issued a refusal to file letter for an NDA from Innocoll for XaraColl bupivacaine collagen-matrix...
...XaraColl should be characterized as a drug/device combination, a complete application would require additional information. Innocoll...
...membrane technology. Innocoll Holdings plc (NASDAQ:INNL), Athlone, Ireland Product: XaraColl bupivacaine collagen-matrix implants Business: Neurology Julian Zhu XaraColl Innocoll...
BioCentury | Nov 22, 2016
Clinical News

XaraColl regulatory update

...Innocoll Holdings plc (NASDAQ:INNL), Athlone, Ireland Product: XaraColl , Bupivacaine collagen sponge Business: Neurology Jaime De Leon XaraColl Innocoll...
BioCentury | Nov 22, 2016
Clinical News

Cogenzia: Ph III COACT-1 and COACT-2 data

...about 10 days post-treatment vs. placebo plus SOC or SOC alone. Cogenzia was well tolerated. Innocoll...
...clinical cure, amputation rate and ulcer closure rate Status: Phase III data Milestone: NA Jaime De Leon Cogenzia Innocoll...
BioCentury | Nov 14, 2016
Clinical News

XaraColl regulatory update

...membrane technology. Innocoll Holdings plc (NASDAQ:INNL), Athlone, Ireland Product: XaraColl bupivacaine collagen-matrix implants Business: Neurology Nora Weintraub XaraColl Innocoll...
BioCentury | Oct 3, 2016
Finance

ASH and others

...III data December Indivior plc (LSE:INDV) RBP-7000 Acute exacerbation of schizophrenia Ph III data 4Q16 Innocoll...
...NASDAQ:INNL) Cogenzia CollaRx gentamicin topical Moderate or severe diabetic foot infections Ph III data 4Q16 Innocoll...
BioCentury | Jul 11, 2016
Finance

Ground up

...comes together quickly. Announcing publicly can be a no-win situation." The most notable example was Innocoll...
...London, U.K. Juno Therapeutics Inc. (NASDAQ:JUNO), Seattle, Wash. Kite Pharma Inc. (NASDAQ:KITE), Los Angeles, Calif. Innocoll...
...6/17/16 $20.1 $138.2 $164.7 16% BioTime Inc. (NYSE-M:BTX; Tel Aviv:BTX) 6/16/16 $17.5 $244.5 $267.0 8% Innocoll...
BioCentury | Jul 11, 2016
Finance

Rethinking risk

...2H16 Horizon Pharma plc (NASDAQ:HZNP) Actimmune interferon gamma-1b Friedreich's ataxia Top-line Ph III data YE16 Innocoll...
...Holdings plc (NASDAQ:INNL) Cogenzia Diabetic foot infections Top-line Ph III COACT-1 and COACT-2 data 2H16 Innocoll...
Items per page:
1 - 10 of 83